211 related articles for article (PubMed ID: 28327183)
1. Modeling multi-mutation and drug resistance: analysis of some case studies.
Feizabadi MS
Theor Biol Med Model; 2017 Mar; 14(1):6. PubMed ID: 28327183
[TBL] [Abstract][Full Text] [Related]
2. Modeling drug resistance in a conjoint normal-tumor setting.
Feizabadi MS; Witten TM
Theor Biol Med Model; 2015 Jan; 12():3. PubMed ID: 25588472
[TBL] [Abstract][Full Text] [Related]
3. Toward a Better Understanding of the Complexity of Cancer Drug Resistance.
Gottesman MM; Lavi O; Hall MD; Gillet JP
Annu Rev Pharmacol Toxicol; 2016; 56():85-102. PubMed ID: 26514196
[TBL] [Abstract][Full Text] [Related]
4. Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach.
Taylor S; Spugnini EP; Assaraf YG; Azzarito T; Rauch C; Fais S
Drug Resist Updat; 2015 Nov; 23():69-78. PubMed ID: 26341193
[TBL] [Abstract][Full Text] [Related]
5. Modeling the Dynamics of Heterogeneity of Solid Tumors in Response to Chemotherapy.
Cho H; Levy D
Bull Math Biol; 2017 Dec; 79(12):2986-3012. PubMed ID: 29022203
[TBL] [Abstract][Full Text] [Related]
6. Mathematical Approach to Differentiate Spontaneous and Induced Evolution to Drug Resistance During Cancer Treatment.
Greene JM; Gevertz JL; Sontag ED
JCO Clin Cancer Inform; 2019 Apr; 3():1-20. PubMed ID: 30969799
[TBL] [Abstract][Full Text] [Related]
7. Mathematical modeling and computational prediction of cancer drug resistance.
Sun X; Hu B
Brief Bioinform; 2018 Nov; 19(6):1382-1399. PubMed ID: 28981626
[TBL] [Abstract][Full Text] [Related]
8. Looking beyond the cancer cell for effective drug combinations.
Dry JR; Yang M; Saez-Rodriguez J
Genome Med; 2016 Nov; 8(1):125. PubMed ID: 27887656
[TBL] [Abstract][Full Text] [Related]
9. Calculated resistance in cancer.
Sawyers CL
Nat Med; 2005 Aug; 11(8):824-5. PubMed ID: 16079872
[No Abstract] [Full Text] [Related]
10. Cancer cells acquire resistance to anticancer drugs: an update.
Lu HP; Chao CC
Biomed J; 2012; 35(6):464-72. PubMed ID: 23442359
[TBL] [Abstract][Full Text] [Related]
11. The effect of intrinsic and acquired resistances on chemotherapy effectiveness.
Menchón SA
Acta Biotheor; 2015 Jun; 63(2):113-27. PubMed ID: 25750013
[TBL] [Abstract][Full Text] [Related]
12. Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinib.
Broxterman HJ; Gotink KJ; Verheul HM
Drug Resist Updat; 2009; 12(4-5):114-26. PubMed ID: 19648052
[TBL] [Abstract][Full Text] [Related]
13. Strategies for Overcoming Resistance in Tumours Harboring BRAF Mutations.
Obaid NM; Bedard K; Huang WY
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28282860
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenomics of intrinsic and acquired pharmacoresistance in colorectal cancer: Toward targeted personalized therapy.
De Mattia E; Cecchin E; Toffoli G
Drug Resist Updat; 2015 May; 20():39-70. PubMed ID: 26027741
[TBL] [Abstract][Full Text] [Related]
15. Addressing intra-tumoral heterogeneity and therapy resistance.
Rybinski B; Yun K
Oncotarget; 2016 Nov; 7(44):72322-72342. PubMed ID: 27608848
[TBL] [Abstract][Full Text] [Related]
16. Drug resistance, epigenetics, and tumor cell heterogeneity.
Hoey T
Sci Transl Med; 2010 Apr; 2(28):28ps19. PubMed ID: 20410528
[TBL] [Abstract][Full Text] [Related]
17. Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance.
Taddia L; D'Arca D; Ferrari S; Marraccini C; Severi L; Ponterini G; Assaraf YG; Marverti G; Costi MP
Drug Resist Updat; 2015 Nov; 23():20-54. PubMed ID: 26690339
[TBL] [Abstract][Full Text] [Related]
18. Crosstalk in cancer resistance and metastasis.
Norouzi S; Gorgi Valokala M; Mosaffa F; Zirak MR; Zamani P; Behravan J
Crit Rev Oncol Hematol; 2018 Dec; 132():145-153. PubMed ID: 30447920
[TBL] [Abstract][Full Text] [Related]
19. Cancer therapy: an evolved approach.
Willyard C
Nature; 2016 Apr; 532(7598):166-8. PubMed ID: 27075079
[No Abstract] [Full Text] [Related]
20. Intrinsic and acquired drug resistance in malignant tumors. The main reason for therapeutic failure.
Lippert TH; Ruoff HJ; Volm M
Arzneimittelforschung; 2008; 58(6):261-4. PubMed ID: 18677966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
